Budoucí P/E společnosti AGNC Investment Corp

Jaká je hodnota metriky Budoucí P/E společnosti AGNC Investment Corp?

Hodnota metriky Budoucí P/E společnosti AGNC Investment Corp je 4.52

Jaká je definice metriky Budoucí P/E?



Budoucí poměr P/E (Forward price to earnings ratio) vyjadřuje poměr současné ceny a odhadovaného zisku na akcii v následujících dvanácti měsících.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Budoucí P/E společností v sektoru Real Estate sektor na NASDAQ ve srovnání se společností AGNC Investment Corp

Čemu se věnuje společnost AGNC Investment Corp?

founded in 2008, agnc investment corp. (nasdaq: agnc) is an internally-managed real estate investment trust that invests primarily in residential mortgage-backed securities guaranteed by a u.s. government agency or a u.s. government-sponsored entity on a leveraged basis. agnc’s principal investment objective is to provide our stockholders with attractive risk-adjusted returns through a combination of monthly dividends and net asset value accretion. as of march 31, 2018, agnc had a market capitalization of $7.4 billion and total assets of $69.2 billion. agnc is the largest internally-managed residential mortgage reit and one of only three residential mortgage reits with a market cap over $5 billion. agnc is headquartered in bethesda, maryland. our affiliates: mtge investment corp. (nasdaq: mtge) is a real estate investment trust that invests in agency and non-agency mortgage backed securities, other mortgage-related investments and healthcare-related real estate investments. mtge is ext

Firmy s metrikou budoucí p/e podobnou společnosti AGNC Investment Corp